Percutaneous image-guided renal ablations: Current evidences for long-term oncologic efficacy

Presse Med. 2019 Jul-Aug;48(7-8 Pt 2):e233-e243. doi: 10.1016/j.lpm.2019.07.015. Epub 2019 Aug 21.

Abstract

The rise in incidentally discovered small renal neoplasms has focused attention on nephron-sparing treatment strategies including partial nephrectomy and percutaneous ablation as well as active surveillance. As all treatment modality, renal ablation has matured technically. Radiofrequency ablation, microwave ablation or cryoablation are now performed in many institutions under imaging guidance. The long-term results allow them to be now recommended as a therapeutic option whatever the patients' condition if complete ablation can reliably be achieved.

Publication types

  • Review

MeSH terms

  • Carcinoma, Renal Cell / epidemiology
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / surgery*
  • Catheter Ablation* / adverse effects
  • Catheter Ablation* / methods
  • Disease-Free Survival
  • Humans
  • Kidney Neoplasms / epidemiology
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Nephrectomy* / adverse effects
  • Nephrectomy* / methods
  • Patient Selection
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Surgery, Computer-Assisted* / adverse effects
  • Surgery, Computer-Assisted* / methods
  • Time Factors
  • Treatment Outcome